🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to evaluate the vaccine efficacy, immunogenicity and...
Status
Recruiting
Location
Liuzhou center for disease control and prevention
Start Date
2020-04-28
Trial ID
NCT04422366
The goal of this clinical trial is to compare a 2-dose and 3-dose series of...
Status
Recruiting
Location
University of Texas Medical Branch
Start Date
2023-01-18
Trial ID
NCT05672927
Treatments Being Tested
The primary objective of this study is the estimation of the human papillom...
Status
Completed
Location
Sotobo Children's Clinic ( Site 6616)
Start Date
2021-05-17
Trial ID
NCT04772534
Treatments Being Tested
A randomized, observer-blind non-inferiority trial to evaluate alternative ...
Status
Unknown
Location
Ed Clarke
Start Date
2019-09-14
Trial ID
NCT03832049
The main purpose of this study was to evaluate the safety and reactogenicit...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-08-22
Trial ID
NCT05496231
Treatments Being Tested
Background: Diseases related to human papillomavirus (HPV) include warts, ...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-02-04
Trial ID
NCT03519464
Treatments Being Tested
This phase II trial studies whether the nonavalent human papillomavirus vac...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2017-06-23
Trial ID
NCT03036930
Primary objective: • To demonstrate that administration of V503 induces no...
Status
Completed
Location
Multiple Locations
Start Date
2011-02-23
Trial ID
NCT01304498
The study will evaluate the immunogenicity and safety of 9-valent HPV recom...
Status
Completed
Location
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Start Date
2020-09-19
Trial ID
NCT05372016
This is a multi-site, open-label non-inferiority study of the 9vHPV vaccine...
Status
Completed
Location
AHF Lamvelase
Start Date
2022-04-01
Trial ID
NCT04982614
Treatments Being Tested